EX-16.1 2 rani-ex16_1.htm EX-16.1 EX-16.1

Exhibit 16.1

 

img163111488_0.jpg

 

 

 

 

April 8, 2025

 

 

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Commissioners:

We have read the statements made by Rani Therapeutics Holdings, Inc. under Item 4.01 of its Form 8-K dated April 7, 2025. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Rani Therapeutics Holdings, Inc. contained therein.

 

Very truly yours,

img163111488_1.jpg

Marcum LLP

 

 

 

 

 

Marcum LLP img163111488_2.jpg One Montgomery Street img163111488_3.jpg Suite 1700 img163111488_3.jpgSan Francisco, California 94104 img163111488_3.jpg Phone 415.432.6200 img163111488_3.jpg Fax 415.432.6201 img163111488_2.jpg marcumllp.com